Eli Lilly and Co (LLY)
767.76
+10.22
(+1.35%)
USD |
NYSE |
Dec 20, 16:00
780.00
+12.24
(+1.59%)
After-Hours: 20:00
Eli Lilly Shareholders Equity (Quarterly): 14.24B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 7.527B |
| Biogen Inc | 16.36B |
| Regeneron Pharmaceuticals Inc | 29.33B |
| Viking Therapeutics Inc | 911.45M |
| Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 75.61B |
| Total Liabilities (Quarterly) | 61.29B |
| Debt to Equity Ratio | 2.185 |
| Current Ratio | 1.273 |
| Net Debt Paydown Yield | -0.31% |